Studies Expand List of High- and Low-Penetrance Variants Implicated in Colorectal Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – A pair of studies online this week in Nature Genetics are providing information on new genetic factors that bump up colorectal cancer risk to varying degrees.

In the first of these, members of the Colorectal Tumor Gene Identification, or CORGI, consortium, the Oxford-Illumina 500 Whole-Genome Sequences, or WGS500, consortium, and others searched for high-penetrance risk factors among individuals with early onset colorectal cancer or related polyp conditions predisposing them to the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.

Mar
30
Sponsored by
SeraCare

Our roundtable of industry experts will provide an overview of the current regulatory landscape for clinical genomics tests.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.